Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Protéus is a French biotechnology company specializing in the discovery, design, and development of industrial enzymes and microbial processes. Founded in 1998 and based in Nîmes, the company utilizes proprietary technologies like L-Shuffling for directed evolution and Phenoscreen for high-throughput screening of microbial diversity. Protéus provides specialized services to the pharmaceutical, cosmetic, and specialty chemical sectors, focusing on biocatalysis to improve manufacturing efficiency and sustainability. Since its acquisition, it has operated as the biotechnology center of excellence for the Seqens group, integrating bio-based solutions into large-scale chemical manufacturing. The company maintains an extensive proprietary collection of microbial strains and enzymes to support rapid process development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Protéus.